Specifically, we asked if metformin, a first-line drug to treat type 2 diabetes, which also alleviates some symptoms in FXS as well as phenotypes in Fmr1 KO mice and flies [27–30], rescued sleep phenotypes. This evidence concerns the gene FMR1 and fragile X syndrome.